# Compare the Effectiveness and Safety of Genoss® DCB and IN.PACT Admiral® DCB in Patients With Peripheral Artery Disease

Study · id `cardio:ct-nct05134545` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05134545](<https://clinicaltrials.gov/study/NCT05134545>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05134545

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 119 participants.

## Technical summary

Registry record NCT05134545. Randomized; double masking; primary purpose treatment. Start 2019-03-24 (actual); primary completion 2022-12-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 119 participants (enrolled count; ClinicalTrials.gov record NCT05134545, source copy `cardio:ctgov-nct05134545-2024-08-23`, retrieved 2026-10-31)
- Started: 2019-03-24 (actual) (ClinicalTrials.gov record NCT05134545, source copy `cardio:ctgov-nct05134545-2024-08-23`, retrieved 2026-10-31)
- Primary completion: 2022-12-30 (actual) (ClinicalTrials.gov record NCT05134545, source copy `cardio:ctgov-nct05134545-2024-08-23`, retrieved 2026-10-31)
- Completion: 2023-06-30 (actual) (ClinicalTrials.gov record NCT05134545, source copy `cardio:ctgov-nct05134545-2024-08-23`, retrieved 2026-10-31)
- Countries: South Korea (ClinicalTrials.gov record NCT05134545, source copy `cardio:ctgov-nct05134545-2024-08-23`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05134545-2024-08-23`, retrieved 2026-10-31)

## The registry's words

- Brief title: Compare the Effectiveness and Safety of Genoss® DCB and IN.PACT Admiral® DCB in Patients With Peripheral Artery Disease
- Condition: Peripheral Artery Disease
- Condition: De Novo Stenosis
- Intervention (Device): Genoss® DCB
- Intervention (Device): IN.PACT Admiral® DCB
- Lead sponsor: Genoss Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Genoss Co., Ltd. (`cardio:org-genoss-co-ltd`)

## Provenance

Content hash: 401a6e3f48a68103c6fb3678bea3d1d3c0ca20a5c0acfad2cda8077e28c600f4
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
